Objective Length of stay (LOS) is a major driver of inpatient care costs. To date, few studies have investigated risk factors associated with increased LOS in patients with adult congenital heart disease (ACHD). In the present work, we sought to address this knowledge gap. Methods We conducted an analysis of the State Inpatient Databases from Arkansas, California, Florida, Hawaii, Nebraska and New York. We analysed data on admissions in patients with ACHD and constructed a series of hierarchical regression models to identify the clinical factors having the greatest effects on LOS. Results We identified 99 103 inpatient hospitalisations meeting criteria for inclusion. Diagnoses associated with the longest LOS were septicaemia (LOS=14.2 days in patients atrial septal defect, and 11.7 days among all other ACHD) and pericarditis, endocarditis and myocarditis (LOS=13.6 days and 10.0 days, respectively). When separated by underlying anatomy, the variables most consistently associated with longer LOS were bacterial infection, complications of surgeries or medical care, acute renal disease and anaemia. Conclusions In the present study, we identified risk factors associated with longer LOS in ACHD. These data may be used to identify at-risk patients for targeted intervention to decrease LOS and thereby cost.
INTRODUCTION
Congenital heart disease (CHD) is the most common form of birth defect in the USA and the world. 1 Advanced surgical and clinical management has allowed an ever-increasing number of these patients who previously would have perished in childhood to survive into adulthood. 2 This growing population of adult survivors with CHD is projected to continue to grow in the coming years, with an accompanying growth in healthcare utilisation. [3] [4] [5] [6] Furthermore, the deterioration of surgical repairs performed in early childhood combined with the inevitable onset of acquired heart disease promises continued increases in healthcare utilisation in this population as they age. 7 8 In particular, inpatient hospitalisation represents a significant cost burden for patients with adult CHD (ACHD) and the healthcare infrastructure alike. 8 9 To our knowledge, however, there has yet to be an in-depth lesion-specific investigation of what risk factors are associated with increased inpatient length of stay (LOS) and which of these factors, if any, may be modifiable. These data are important to provide guidance for the development of treatment algorithms designed to minimise LOS without compromising health outcomes and quality of life in the ACHD population. The purpose of the current study was therefore to identify predictors of increased LOS in patients with ACHD.
METHODS
For this analysis, State Inpatient Databases (SIDs) were used which are part of the Healthcare Cost and Utilization Project. 10 We specifically used the SIDs for Arkansas (2008) (2009) (2010) , California (2003 California ( -2012 , Florida (2005 Florida ( -2012 , Hawaii (2006 Hawaii ( -2010 , Nebraska (2003 Nebraska ( -2011 and New York (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . We selected these SIDs because they uniquely track hospitalisations in individual patients longitudinally, whereas data from other states track hospitalisations without tracking patients risking repeated sampling of the same patient. The dates used were the most complete and up to date available at the time of analysis in April 2015. The primary outcome was LOS for hospitalisations among patients with ACHD in the states investigated. The present study was approved by the Institutional Review Board at Washington University School of Medicine.
As a first step, we identified patients in the databases with ACHD by selecting patients in the SIDs with an age of greater than 18, and with a three-digit International Classification of Diseases-Ninth Revision (ICD-9) diagnosis code of 745, 746 or 747-the administrative codes that identify congenital cardiovascular anomalies. To this group of patients, we applied a validated hierarchical algorithm described by Broberg et al 11 to categorise patients based on anatomy. Patients categorised as having a shunt according to this algorithm who had only the ICD-9 code for atrial septal defect (ASD, 745.5) were analysed separately from the rest of the group of patients categorised as having shunts due to the inclusion of patent foramen ovale (PFO) in this coding group and the desire to prevent contaminating the analysis of shunt lesions with what is generally considered to be a variant of normal atrial septal anatomy. Patients who failed to be classified according to this algorithm were excluded to increase the probability that all the patients included for analysis in fact had ACHD. We next identified all hospitalisations during the study period among patients meeting inclusion criteria. We included only initial hospitalisations during the study period for any individual patient to avoid repeated sampling of the same patient. We also omitted hospitalisations with missing LOS data and trimmed the upper 1% to exclude extreme outliers.
Next, we constructed a series of hierarchical (patient, hospital, state) multivariable regression models to examine our primary outcome of interest: LOS. All models treat site of hospitalisation and US state as random effects. A different model for each congenital heart lesion group as defined by the hierarchical algorithm was constructed using preidentified variables based on anticipated clinical significance. In addition, we constructed separate models for admissions during which an operative procedure took place and those without in recognition of the potential impact of operative procedures on LOS and on the clinical variables effecting LOS. From these overall models, patients categorised as having an isolated ASD based on the hierarchical algorithm were excluded to avoid contaminating the sample with patients having only a PFO, as explained above. Each model included the same set of independent variables, which can be found in the online Supplemental material. As the purpose of these models was descriptive not predictive, variables were not excluded for the sake of parsimony and given large sample size, overfitting was not a concern. The sample size of each model changed due to the varying number of subjects in each diagnosis group. The reference value is zero ('no') for each dichotomous variable included in the models. The estimated contribution to LOS in days, 95% CI, and p-values were reported from these models and all significance tests were two sided with type I error set to 5%, that is, α=0.05. All analyses were conducted using SAS V.9.4.
RESULTS

Patient characteristics
We identified 99 103 unique index hospitalisations from our dataset meeting criteria for inclusion in this study (figure 1). Average age in our population was 57.1±18.5 years, and 50.0% were female. The majority were white (69.7%) and from urban locations (67.3%). Further demographic information can be found in table 1. Tables 2 and 3 list the 15 most common admitting diagnoses among patients with an ASD and among other patients with ACHD, respectively, with associated mean LOS. These diagnoses represent 72% of the total number of admissions in patients with ASD, and 69% of admissions among other patients with ACHD. When the admission diagnosis of cardiac and circulatory congenital anomalies is omitted, the most common admitting diagnoses among patients with an ASD were for acute cerebrovascular disease (n=10 698) and heart valve disorders (n=4046), while the most common admitting diagnoses among patients with ACHD without an ASD were heart valve disorders (5003) and coronary atherosclerosis (3823). Of the top 15 admitting diagnoses, those that were associated with the longest LOS among patients with an ASD Figure 1 Inclusion and exclusion diagram: graphical representation of the patients included in the present analysis. 155 297 index admissions were found. Admission data were then excluded if patients failed to be categorised by the algorithm to identify ACHD lesion and if records were missing LOS information required for analysis yielding 109 450 total admissions. Repeated admissions or records were then removed resulting in 100 067 index admissions for individual patients. After trimming the top 1% to remove outliers, this resulted in a final tally of 99 103 admissions which were used for analysis. LOS, length of stay. AS/BAV, aortic stenosis/bicuspid aortic valve; ASD, atrial septal defect; AVCD, atrioventricular canal defect; CHD, congenital heart disease; Coenzyme A, coarctation of the aorta; PS, pulmonary valve stenosis; PVC, pulmonary venous connection; TGA, transposition of the great arteries. (in days) were septicaemia (mean LOS=14.2) and pericarditis, endocarditis and myocarditis (mean LOS=13.6). Similarly, among patients with ACHD without an ASD, they were septicaemia (mean LOS=11.7), and pericarditis, endocarditis and myocarditis (mean LOS=10.0).
Most common admission diagnoses
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LOS by type of ACHD
When separated by type of ACHD, the longest average LOS was seen in patients with subaortic stenosis (7.4±7.7 days) and isolated ASD (7.3±8.2 days), while the shortest average LOS was seen among patients with anomalous coronary arteries (4.6±5.5 days) and pulmonary stenosis (5.5±6.5 days) (figure 2).
Predictors of increased LOS
Among all ACHD admissions having an operative procedure during their hospitalisation, excluding patients with an ASD, the variables associated with the greatest increase in LOS were bacterial infection (6.2 days longer, 95% CI 5.9 to 6.6, p<0.0001), acute kidney disease (3.3 days longer, 95% CI 2.8 to 3.8, p<0.0001), having 'no charge' as the primary payer (2.4 days longer, 95% CI 0.8 to 4.1, p=0.0036), pulmonary heart disease (2.1 days longer, 95% CI 1.6 to 2.5, p<0.0001), congestive heart failure (2.0 days longer, 95% CI 1.7 to 2.4, p<0.0001), complications of surgeries or medical care (1.9 days longer, 95% CI 1.6 to 2.2, p<0.0001) 
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and anaemia (1.8 days longer, 95% CI 1.5 to 2.1, p<0.0001). Among all ACHD admissions without an operative procedure, excluding patients with an ASD, the variables associated with the greatest increase in LOS were having had an aortic valve operation (16.1 days longer, 95% CI 15.0 to 17.4, p<0.0001), complications of surgeries or medical care (4.0 days longer, 95% CI 3.4 to 4.7, p<0.0001), acute kidney disease (2.9 days longer, 95% CI 2.5 to 3.4, p<0.0001), bacterial infection (2.9 days longer, 95% CI 2.6 to 3.2, p<0.0001), coagulopathy (2.4 days longer, 95% CI 1.9 to 2.9, p<0.0001) and having subaortic stenosis (2.1 days longer, 95% CI 0.8 to 3.5, p=0.0016). All variables having a significant impact on LOS for admissions with and without operative procedures are listed in online Supplemental Tables 1 and 2 , respectively. Due to the heterogeneity of ACHD, we next sought to identify lesion-specific variables associated with increased LOS. Included in this analysis was an assessment of variables affecting LOS specifically in the population of patients with an isolated ASD which had been excluded from the above models. All variables having a significant impact on LOS separated by lesion type, are listed in online Supplemental Table 3 . Although we found significant heterogeneity among lesions, the variables most consistently associated with increased LOS across ACHD categories were bacterial infection, complications of surgeries or medical care, acute renal disease and anaemia.
DISCUSSION
In the present study, we investigated clinical variables associated with increased LOS among hospitalised patients with ACHD. We found that overall, the variables most strongly associated with increased LOS, regardless of underlying anatomy, were acute kidney failure, bacterial infection, complications from medical or surgical procedures and anaemia.
For the present analysis, we analysed patients with ACHD who had an isolated ASD separately from the rest of the ACHD group. We did so due to the well-described limitation in the ICD-9 coding system, whereby there is no mechanism for differentiation between ASD and PFO. A large proportion of patients falling into this category in the present analysis likely had PFOs (which are very common) as opposed to ASDs (which are far less common). As such, extrapolation of the present data to the ASD population may be limited. Importantly, we found that over 50% of the total ACHD population identified by ICD-9 codes alone fall into this category, suggesting that research based on administrative data which fail to analyse lesions separately may arrive at conclusions relevant predominantly to the population of patients with PFOs. This limitation has not been addressed in the new ICD-10 coding system and will therefore continue to be a limitation to ACHD research into the future.
Most of the hospitalisations in the present dataset were for cardiac conditions. This is expected and largely reproduces other reports on the most common reasons for hospitalisation in patients with ACHD 12 (also reviewed in Avila et al). 9 Interestingly, we found that one of the most common reasons for admission in patients with ASD specifically was cerebrovascular disease. We suspect that this is attributable to the fact that ICD-9 does not differentiate between ASD and PFO, both of which are coded as 745.5. As up to 20% of the general population have a PFO, the high incidence of hospitalisation for cerebrovascular disease among the ASD group is likely due to patients admitted with stroke in whom imaging studies obtained to identify the aetiology of the event incidentally find a PFO. We also found that complications of device implants or grafts, infections involving the heart and septicaemia are among the most common reasons for hospitalisation in ACHD patients both with and without ASDs. Given their condition, patients with ACHD undergo medical procedures more frequently than age-matched patients without ACHD. The frequency with which patients with ACHD are admitted with these diagnoses suggests periprocedural care as a high-yield area for potential quality improvement.
The LOS reported in the present study is similar to that which has been previously reported. Compared with the data from the Dutch CONCOR database of patients with ACHD hospitalised from 2001 to 2006, 12 our study found a slightly longer mean LOS for all lesions. This slight difference in LOS may be explained by differences in clinical practices between the USA and the Netherlands. In support of this conclusion, a study using the National Inpatient Sample to investigate trends in ACHD hospitalisationfrom Opotowsky et al found an overall average LOS of 5.6±0.1 days, comparable to the findings of the present study. 4 Although this study investigated the frequency of hospitalisation among various types of ACHD, they did not report lesion -specific differences in LOS.
In the present study, we found that across groups, many of the variables strongly associated with increased LOS were both acute, and potentially modifiable. These included bacterial infections, complications of surgeries or medical care, acute renal disease and anaemia. There is the potential that rates of medical or surgical complications and bacterial infection may be minimised through protocols to optimise preoperative and postoperative care, intraoperative technique and prophylactic antibiotic use, respectively. Similarly, protocols can be implemented to increase vigilance for and prevention of acute kidney injury during and between hospitalisations. These potentially modifiable risk factors are clear and actionable targets for hospital-based treatment algorithms to minimise LOS in patients with ACHD and, in turn, improve care quality in this patient population.
It is interesting that chronic comorbidities such as hypertension and chronic kidney disease were not strongly associated with increased LOS in ACHD. This finding seems to conflict with existing data. Using the Charlson comorbidity score in a Canadian population, Mackie et al 5 demonstrated that patients with ACHD with a greater comorbid burden utilise more healthcare services in general, athough they did not report specifically on LOS. In the USA, Opotowsky et al 4 studied the effects of comorbidity on LOS in ACHD and found that increasing numbers of medical comorbidities correlated with increased LOS. The lack of correlation between these comorbid conditions and LOS in the current study may have multiple explanations. The present population differs from that in Canada, and from the population investigated by Opotowsky et al, the latter both in the years and the states investigated. More importantly, however, coding for comorbidities in these two studies was very different from that in the present study. Whereas we investigated specific variables that we believed would be associated with increased LOS; in these two works the authors used a composite score (the Charlson comorbidity index and Elixhauser's list of comorbidities respectively). We did not exhaustively include all comorbidities included in either of these scoring systems, and as such may have missed the variables responsible for the effects of comorbidities on LOS seen in these two works. Alternatively, although the composite of all comorbidities included in these indices may have had a significant impact on LOS in these studies, individual comorbidities taken in isolation may not have been found to be significant, which would have been necessary for detection in the present analysis.
LIMITATIONS
There are multiple limitations to the present study due predominantly to the use of administrative data. The accuracy and completeness of the data depend on the care with which data were entered, which is likely variable from institution to institution. Although we made every effort to include all patients with ACHD, to exclude patients not having ACHD and to correctly characterise patients based on underlying anatomy, no algorithm is perfect, and it is almost certain that some patients in the present study were mischaracterised. Finally, although geography including state of hospitalisation may influence cost and outcomes, the states represented in the present analysis are limited, and this may have biased our results.
CONCLUSIONS
In the present study, we identified potentially modifiable risk factors associated with increased LOS in ACHD. We anticipate that these data may be used to design targeted interventions to decrease LOS and potentially cost in ACHD inpatient care.
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